Abstract Background We examined models to predict disease activity transitions from moderate to low or severe and associated factors in patients with rheumatoid arthritis (RA). Methods Data from RA patients enrolled in the Corrona registry (October 2001 to August 2014) were analyzed. Clinical Disease Activity Index (CDAI) definitions were used for low (≤10), moderate (>10 and ≤22), and severe (>22) disease activity states. A Markov model for repeated measures allowing for covariate dependence was used to model transitions between three (low, moderate, severe) states and estimate population transition probabilities. Mean sojourn times were calculated to compare length of time in particular states. Logistic regression models were used to exam...
Objective—The study aims to examine the threshold in disease activity associated with switching biol...
Objective Although treat-to-target (T2T) strategies are effective in early rheumatoid arthritis (RA)...
Our objective was to identify distinct trajectories of disease activity state (DAS) and assess varia...
BACKGROUND: We examined models to predict disease activity transitions from moderate to low or sever...
Abstract Background The emphasis on treating rheumatoid arthritis (RA) intensively reduces disease a...
Aims: Composite indices for quantifying rheumatoid arthritis (RA) disease activity such as the 28‐jo...
Objective. When treatments with the potential to change the natural history of a disease are introdu...
OBJECTIVE: Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Objective. To assess patient-reported variables as predictors of change in disease activity and disa...
Background: Data regarding the real-life predictors of low disease activity (LDA) in rheumatoid arth...
Objective. Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Introduction In the new millennium, clinical outcomes in patients with rheumatoid arthritis (RA) ha...
<div><p>Our objective was to identify distinct trajectories of disease activity state (DAS) and asse...
Objective. Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Introduction Rheumatoid arthritis is a chronic inflammatory disease with different disease activity ...
Objective—The study aims to examine the threshold in disease activity associated with switching biol...
Objective Although treat-to-target (T2T) strategies are effective in early rheumatoid arthritis (RA)...
Our objective was to identify distinct trajectories of disease activity state (DAS) and assess varia...
BACKGROUND: We examined models to predict disease activity transitions from moderate to low or sever...
Abstract Background The emphasis on treating rheumatoid arthritis (RA) intensively reduces disease a...
Aims: Composite indices for quantifying rheumatoid arthritis (RA) disease activity such as the 28‐jo...
Objective. When treatments with the potential to change the natural history of a disease are introdu...
OBJECTIVE: Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Objective. To assess patient-reported variables as predictors of change in disease activity and disa...
Background: Data regarding the real-life predictors of low disease activity (LDA) in rheumatoid arth...
Objective. Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Introduction In the new millennium, clinical outcomes in patients with rheumatoid arthritis (RA) ha...
<div><p>Our objective was to identify distinct trajectories of disease activity state (DAS) and asse...
Objective. Based on comparisons of short-term cohort studies or cross-sectional samples of patients ...
Introduction Rheumatoid arthritis is a chronic inflammatory disease with different disease activity ...
Objective—The study aims to examine the threshold in disease activity associated with switching biol...
Objective Although treat-to-target (T2T) strategies are effective in early rheumatoid arthritis (RA)...
Our objective was to identify distinct trajectories of disease activity state (DAS) and assess varia...